Role of Age in the Spread of Influenza, 2011–2019: Data From the US Influenza Vaccine Effectiveness Network

Intraseason timing of inf luenza infection among persons of different ages could ref lect relative contributions to propagation of seasonal epidemics and has not been examined among ambulatory patients. Using data from the US Inf luenza Vaccine Effectiveness Network, we calculated risk ratios derived from comparing weekly numbers of inf luenza cases prepeak with those postpeak during the 2010–2011 through 2018–2019 inf luenza seasons. We sought to determine age-specific differences during the ascent versus descent of an inf luenza season by inf luenza virus type and subtype. We estimated 95% credible intervals around the risk ratios using Bayesian joint posterior sampling of weekly cases. Our population consisted of ambulatory patients with laboratory-confirmed inf luenza who enrolled in an inf luenza vaccine effectiveness study at 5 US sites during 9 inf luenza seasons after the 2009 inf luenza A virus subtype H1N1 (H1N1) pandemic. We observed that young children aged <5 years tended to more often be infected with H1N1 during the prepeak period, while adults aged ≥65 years tended to more often be infected with H1N1 during the postpeak period. However, for inf luenza A virus subtype H3N2, children aged <5 years were more often infected during the postpeak period. These results may ref lect a contribution of different age groups to seasonal spread, which may differ by inf luenza virus type and subtype.

[1]  A. Monto,et al.  Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility , 2020, Nature Communications.

[2]  D. Skowronski,et al.  Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV) , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  E. Belongia,et al.  Influenza Vaccine Effectiveness: Defining the H3N2 Problem. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  E. Belongia,et al.  Earliest infections predict the age distribution of seasonal influenza A cases , 2019, eLife.

[5]  Katelyn M. Gostic,et al.  Childhood immune imprinting to influenza A shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics , 2019, PLoS pathogens.

[6]  L. Brammer,et al.  Birth Cohort Effects in Influenza Surveillance Data: Evidence that First Influenza Infection Affects Later Influenza-Associated Illness. , 2019, The Journal of infectious diseases.

[7]  A. Monto,et al.  Influence of Birth Cohort on Effectiveness of 2015–2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States , 2018, The Journal of infectious diseases.

[8]  Ivo M Foppa,et al.  Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness , 2018, Influenza and other respiratory viruses.

[9]  D. Skowronski,et al.  Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015–2016 Season in Canada , 2017, The Journal of infectious diseases.

[10]  A. Monto,et al.  The Doctrine of Original Antigenic Sin: Separating Good From Evil , 2017, The Journal of infectious diseases.

[11]  S. Hensley,et al.  Immune history and influenza virus susceptibility. , 2017, Current opinion in virology.

[12]  James O. Lloyd-Smith,et al.  Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting , 2016, Science.

[13]  Marc Lipsitch,et al.  On the relative role of different age groups in influenza epidemics. , 2015, Epidemics.

[14]  Trevor Bedford,et al.  Global circulation patterns of seasonal influenza viruses vary with antigenic drift , 2015, Nature.

[15]  Richard K. Zimmerman,et al.  Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type , 2014, The Journal of infectious diseases.

[16]  A. Monto,et al.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  A. Monto,et al.  Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Louise Pelletier,et al.  Age-specific Differences in Influenza A Epidemic Curves: Do Children Drive the Spread of Influenza Epidemics? , 2011, American journal of epidemiology.

[19]  J Wallinga,et al.  Distribution of vaccine/antivirals and the ‘least spread line’ in a stratified population , 2010, Journal of The Royal Society Interface.

[20]  M. van Boven,et al.  Optimizing infectious disease interventions during an emerging epidemic , 2009, Proceedings of the National Academy of Sciences.

[21]  B. Flannery,et al.  Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012–2013 Through 2017–2018 , 2021 .